Daniel L. Menichella serves as Executive at Talecris Biotherapeutics Holdings Corp., where they oversee executive responsibilities. Since joining the company, Daniel L. Menichella has executed 12 insider transactions totaling $2.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 8, 2021 involved purchasing 20,000 shares valued at $230.0K.
Daniel L. Menichella currently holds 20,000 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel L. Menichella has been a net seller of TLCR stock. They have purchased $230.0K and sold $2.4M worth of shares.
Daniel L. Menichella's most recent insider trade was on Feb 8, 2021, when they purchased 20,000 shares at $11.50 per share.
Get notified when new Form 4 filings are submitted
| $24.90 |
| Discretionary |
| Jan 23, 2015 | AGTC | $9.8K | Option Exercise | 1,996 | $4.90 | Discretionary |
| Dec 22, 2014 | AGTC | $44.1K | Option Exercise | 9,000 | $4.90 | Discretionary |
| Dec 22, 2014 | AGTC | $187.5K | Sale | 9,000 | $20.83 | Discretionary |
| Jun 1, 2011 | TLCR | $0 | Disposition | 19,317 | $N/A | Discretionary |
| Apr 1, 2011 | TLCR | $0 | Award | 4,357 | $N/A | Discretionary |
| Apr 1, 2011 | TLCR | $55.3K | Payment | 2,053 | $26.94 | Discretionary |
| Aug 30, 2010 | TLCR | $1.1M | Option Exercise | 100,000 | $11.00 | Discretionary |
| Aug 30, 2010 | V9SNS*IJ | $2.2M | Sale | 100,000 | $22.05 | Discretionary |
| Oct 29, 2009 | TLCR | $51.3K | Payment | 2,596 | $19.75 | Discretionary |
| Sep 30, 2009 | TLCR | $0 | Award | 5,921 | $N/A | Discretionary |